Laboratorio de Farmacología, Dep. de Fisiología y Farmacología, Facultad de Farmacia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, 37007, Salamanca, Spain.
Unidad de Fisiopatología Renal y Cardiovascular, Instituto Reina Sofía de Investigación Nefrológica, Dep. de Fisiología y Farmacología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, 37007, Salamanca, Spain.
Pflugers Arch. 2020 Dec;472(12):1693-1703. doi: 10.1007/s00424-020-02452-8. Epub 2020 Aug 21.
The dopaminergic system influences the heart rhythm by inhibiting the rat cardiac sympathetic and parasympathetic neurotransmissions through activation of D-like receptors (encompassing the D, D, and D subtypes). Whereas D receptor subtype activation results in cardiac sympatho-inhibition, the dopamine receptor subtypes involved in rat cardiac vago-inhibition remain unknown. Hence, this study investigated the specific functional role of the D-like receptor subtypes (D, D, and/or D) inhibiting the rat heart cholinergic drive. For this purpose, male Wistar rats were pithed and prepared for cardiac vagal stimulation. Bradycardic responses were obtained by electrical stimulation of vagal fibres (3, 6, 9 Hz; n = 100) or i.v. acetylcholine (ACh; 1, 5, 10 μg/kg; n = 15). Expression of D, D, and D receptors was studied in left and right atrium samples by PCR (n = 4). Intravenous injections of quinpirole (D-like agonist; 1-30 μg/kg), but not of SFK-38393 (D-like agonist; 1-30 μg/kg), dose-dependently inhibited the vagally induced bradycardia. The vago-inhibition induced by quinpirole (which failed to affect the bradycardia to i.v. ACh) was unchanged after i.v. injections of the antagonists L-741,626 (D; 100 μg/kg) or SB-277011-A (D; 100 μg/kg), but it was abolished by L-745,870 (D; 100 μg/kg). mRNA levels of D, D, and D receptor subtype were detected in the left and right rat atria. Our results suggest that the quinpirole-induced vagolytic effect involves prejunctional D receptor subtypes, located in the left and right atria. This provides new evidence on the relevance of D receptor modulating the heart parasympathetic control.
多巴胺能系统通过激活 D 样受体(包括 D、D 和 D 亚型)抑制大鼠心脏交感和副交感神经传递来影响心率。虽然 D 受体亚型的激活导致心脏交感神经抑制,但参与大鼠心脏迷走神经抑制的多巴胺受体亚型仍不清楚。因此,本研究旨在研究 D 样受体亚型(D、D 和/或 D)抑制大鼠心脏胆碱能驱动的特定功能作用。为此,雄性 Wistar 大鼠被去颅并准备进行心脏迷走神经刺激。通过刺激迷走神经纤维(3、6、9 Hz;n = 100)或静脉内注射乙酰胆碱(ACh;1、5、10 μg/kg;n = 15)获得心动过缓反应。通过 PCR(n = 4)研究左、右心房样本中 D、D 和 D 受体的表达。静脉注射喹吡罗尔(D 样激动剂;1-30 μg/kg)而非 SFK-38393(D 样激动剂;1-30 μg/kg)可剂量依赖性地抑制迷走神经诱导的心动过缓。喹吡罗尔(不影响静脉内注射 ACh 引起的心动过缓)诱导的迷走神经抑制在静脉注射拮抗剂 L-741,626(D;100 μg/kg)或 SB-277011-A(D;100 μg/kg)后没有改变,但在静脉注射 L-745,870(D;100 μg/kg)后被消除。在左、右大鼠心房中检测到 D、D 和 D 受体亚型的 mRNA 水平。我们的结果表明,喹吡罗尔诱导的迷走神经松弛作用涉及位于左、右心房的突触前 D 受体亚型。这为 D 受体调节心脏副交感神经控制的相关性提供了新的证据。